CannBioRx Short Term Debt from 2010 to 2025

ATNFW Stock  USD 0.01  0.0005  6.10%   
CannBioRx Life Short Term Debt yearly trend continues to be fairly stable with very little volatility. Short Term Debt is likely to outpace its year average in 2025. During the period from 2010 to 2025, CannBioRx Life Short Term Debt regression line of quarterly data had mean square error of 1.7 T and geometric mean of  630,957. View All Fundamentals
 
Short Term Debt  
First Reported
2019-09-30
Previous Quarter
429 K
Current Value
473.1 K
Quarterly Volatility
1.2 M
 
Covid
Check CannBioRx Life financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among CannBioRx Life's main balance sheet or income statement drivers, such as Interest Expense of 48.98, Selling General Administrative of 7.6 M or Interest Income of 0.0, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or Days Sales Outstanding of 0.0. CannBioRx financial statements analysis is a perfect complement when working with CannBioRx Life Valuation or Volatility modules.
  
Check out the analysis of CannBioRx Life Correlation against competitors.

Latest CannBioRx Life's Short Term Debt Growth Pattern

Below is the plot of the Short Term Debt of CannBioRx Life Sciences over the last few years. It is CannBioRx Life's Short Term Debt historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in CannBioRx Life's overall financial position and show how it may be relating to other accounts over time.
Short Term Debt10 Years Trend
Slightly volatile
   Short Term Debt   
       Timeline  

CannBioRx Short Term Debt Regression Statistics

Arithmetic Mean1,372,530
Geometric Mean630,957
Coefficient Of Variation103.85
Mean Deviation1,183,993
Median1,034,124
Standard Deviation1,425,388
Sample Variance2T
Range3.5M
R-Value0.45
Mean Square Error1.7T
R-Squared0.20
Significance0.08
Slope135,142
Total Sum of Squares30.5T

CannBioRx Short Term Debt History

20251.5 M
2024930.7 K
2023M
20221.3 M
20211.9 M
20203.7 M

About CannBioRx Life Financial Statements

CannBioRx Life investors use historical fundamental indicators, such as CannBioRx Life's Short Term Debt, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in CannBioRx Life. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Short Term Debt930.7 K1.5 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for CannBioRx Stock Analysis

When running CannBioRx Life's price analysis, check to measure CannBioRx Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CannBioRx Life is operating at the current time. Most of CannBioRx Life's value examination focuses on studying past and present price action to predict the probability of CannBioRx Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CannBioRx Life's price. Additionally, you may evaluate how the addition of CannBioRx Life to your portfolios can decrease your overall portfolio volatility.